Medicare Enrolled
Dr. James Leavitt, M.D.
Gastroenterology · Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Leavitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leavitt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Leavitt
Dr. James Leavitt is a gastroenterology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Leavitt performed 1,999 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Leavitt received a total of $17,682 from 53 pharmaceutical and/or device companies across 343 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Leavitt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in FL
$17,682 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 29038 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,999
Medicare services
Top 14% in FL for gastroenterology
Not available
Unique patients (not deduplicated)
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,270 | $26 | $231 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
199 | $71 | $237 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $98 | $348 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
75 | $230 | $1,426 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
69 | $8 | $9 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
69 | $52 | $192 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
44 | $54 | $1,194 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
38 | $84 | $1,496 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
34 | $204 | $1,103 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $133 | $542 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
23 | $109 | $1,000 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
23 | $208 | $1,095 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
12 | $54 | $245 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $84 | $358 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
64.7% high complexity
7.0% medium
28.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,682
Total received (2018-2024)
Avg $2,526/year across 7 years
Top 9% in FL for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
343
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,922
2023
$710
2022
$2,641
2021
$1,719
2020
$2,007
2019
$4,430
2018
$1,253
Payments by company (2024)
Echosens North America, Inc.
$3,600
ABBVIE INC.
$566
Phathom Pharmaceuticals, Inc.
$176
Exact Sciences Corporation
$73
GENZYME CORPORATION
$70
Lilly USA, LLC
$63
Ipsen Biopharmaceuticals, Inc
$52
Intercept Pharmaceuticals, Inc.
$49
PFIZER INC.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$43
Medtronic, Inc.
$42
Celltrion USA Inc.
$24
Ardelyx, Inc.
$21
EVOKE PHARMA, INC.
$20
Merck Sharp & Dohme LLC
$20
Boston Scientific Corporation
$16
Gilead Sciences, Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Braintree Laboratories, Inc.
$13
Top 3 companies account for 88.2% of 2024 payments
All-time payments by company (2018-2024) ›
Echosens North America, Inc.
$3,600
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,734
PENTAX of America, Inc.
$2,545
E.R. Squibb & Sons, L.L.C.
$1,760
Janssen Biotech, Inc.
$1,058
ABBVIE INC.
$1,043
Takeda Pharmaceuticals U.S.A., Inc.
$674
PFIZER INC.
$344
AbbVie, Inc.
$295
Medtronic, Inc.
$265
Daiichi Sankyo Inc.
$235
Boston Scientific Corporation
$226
Synergy Pharmaceuticals Inc
$200
Phathom Pharmaceuticals, Inc.
$191
BOSTON SCIENTIFIC CORPORATION
$184
AbbVie Inc.
$184
QOL Medical, LLC
$154
Janssen Scientific Affairs, LLC
$136
Olympus America Inc.
$128
GENZYME CORPORATION
$112
Gilead Sciences, Inc.
$102
Intercept Pharmaceuticals, Inc.
$94
Merck Sharp & Dohme Corporation
$91
RedHill Biopharma Inc.
$88
Endo Pharmaceuticals Inc.
$86
Ardelyx, Inc.
$83
Lilly USA, LLC
$82
FUJIFILM Medical Systems USA, Inc.
$73
Exact Sciences Corporation
$73
INTERCEPT PHARMACEUTICALS, INC.
$70
Shire North American Group Inc
$70
Covidien LP
$69
Romark Laboratories, LC
$54
Regeneron Healthcare Solutions, Inc.
$54
Ipsen Biopharmaceuticals, Inc
$52
Celgene Corporation
$51
Merck Sharp & Dohme LLC
$44
Johnson & Johnson Health Care Systems Inc.
$43
Ferring Pharmaceuticals Inc.
$39
Nestle HealthCare Nutrition Inc.
$39
Allergan Inc.
$35
Ironwood Pharmaceuticals, Inc
$29
Allergan, Inc.
$26
Celltrion USA Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
EVOKE PHARMA, INC.
$20
Aries Pharmaceuticals, Inc.
$19
Shionogi Inc
$17
UCB, Inc.
$17
Alfasigma USA, Inc.
$16
Braintree Laboratories, Inc.
$13
Prometheus Laboratories Inc.
$12
Napo Pharmaceuticals Inc
$8
Top 3 companies account for 50.2% of all-time payments
Associated products mentioned in payments ›
ACQUIRE · ARIETTA · Aemcolo · Alinia Tablets 500mg 30 count bottle · CIMZIA · CLENPIQ · CYLTEZO · CapsoCam Plus · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · ELEVIEW · ENTYVIO · EOHILIA · ESD - Core Endoscopy · Entyvio · Epclusa · FibroScan · GATTEX · GENERAL THERAPIES · GENERAL THERAPIES · GENERAL - THERAPIES · GI GENIUS · GIMOTI · General - Therapies · HUMIRA · Humira · IBSRELA · IMAGAGINA · IMAGINA · INFLECTRA · INJECTAFER · IQIRVO · LINZESS · Linzess · MOVIPREP · Mulpleta · Mytesi · N/A · NASCOBAL · OCALIVA · OMVOH · PillCam · RENFLEXIS · RINVOQ · Resolution 360 Clip · SKYRIZI · STELARA · SUTAB · Smart Pill · Sucraid · TRULANCE · Talicia · Trulance · VEGZELMA · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA · ZINPLAVA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
192
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL OF MIAMI
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Leavitt is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Leavitt experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Leavitt performed 1,270 infliximab infusion (remicade) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Leavitt receive payments from pharmaceutical companies?
Yes. Dr. Leavitt received a total of $17,682 from 53 companies across 343 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leavitt's costs compare to other gastroenterologists in Miami?
Dr. Leavitt's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leavitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Miami
Browse gastroenterologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in FL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in FL
Which FL gastroenterologists receive the most from drug and device companies.
By company
Echosens North America, Inc. Payments to Doctors
See all physicians who received payments from Echosens North America, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
PENTAX of America, Inc. Payments to Doctors
See all physicians who received payments from PENTAX of America, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology